KRTAP20-2
gene geneOn this page
Also known as KAP20.2
Summary
KRTAP20-2 (keratin associated protein 20-2, HGNC:18944) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 20-2 (Q3LI61). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in cytosol.
Source: NCBI Gene 337976 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_181616
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18944 |
| Approved symbol | KRTAP20-2 |
| Name | keratin associated protein 20-2 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP20.2 |
| Ensembl gene | ENSG00000184032 |
| Ensembl biotype | protein_coding |
| Entrez | 337976 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000330798
RefSeq mRNA: 1 — MANE Select: NM_181616
NM_181616
CCDS: CCDS13604
Canonical transcript exons
ENST00000330798 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001293539 | 30635206 | 30635619 |
Expression profiles
Bgee: expression breadth broad, 19 present calls, max score 81.65.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0085 / max 7.7505, expressed in 4 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 188781 | 0.0085 | 4 |
Top tissues by expression
107 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.65 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 67.39 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| skin of leg | UBERON:0001511 | 32.92 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| zone of skin | UBERON:0000014 | 32.03 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| skin of abdomen | UBERON:0001416 | 30.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| islet of Langerhans | UBERON:0000006 | 27.18 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| blood | UBERON:0000178 | 25.94 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| leukocyte | CL:0000738 | 25.73 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| monocyte | CL:0000576 | 25.55 | gold quality |
| pancreas | UBERON:0001264 | 24.84 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.82 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 20-2 — Q3LI61 (reviewed: Q3LI61)
All UniProt accessions (1): Q3LI61
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 20 family.
RefSeq proteins (1): NP_853647* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021743 | KRTAP_type8/19/20/21/22 | Family |
| IPR052878 | KRTAP_matrix | Family |
Pfam: PF11759
UniProt features (4 total): sequence variant 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LI61-F1 | 45.16 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 27 (showing top):
chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN, GOCC_SUPRAMOLECULAR_POLYMER, TATA_01, GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN, GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP, NOTCH3_TARGET_GENES, GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN, GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP, GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP, GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
106 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP20-2 | KRTAP22-1 | Q3MIV0 | 877 |
| KRTAP20-2 | SCYGR1 | A0A286YEY9 | 870 |
| KRTAP20-2 | KRTAP15-1 | Q3LI76 | 840 |
| KRTAP20-2 | KRTAP24-1 | Q3LI83 | 830 |
| KRTAP20-2 | KRTAP13-3 | Q3SY46 | 792 |
| KRTAP20-2 | KRTAP6-3 | Q3LI67 | 791 |
| KRTAP20-2 | KRTAP26-1 | Q6PEX3 | 791 |
| KRTAP20-2 | KRTAP6-2 | Q3LI66 | 783 |
| KRTAP20-2 | KRTAP6-1 | Q3LI64 | 782 |
| KRTAP20-2 | KRTAP7-1 | Q8IUC3 | 776 |
| KRTAP20-2 | KRTAP13-1 | Q8IUC0 | 772 |
| KRTAP20-2 | KRTAP8-1 | Q8IUC2 | 767 |
| KRTAP20-2 | KRTAP27-1 | Q3LI81 | 720 |
| KRTAP20-2 | KRTAP11-1 | Q8IUC1 | 678 |
| KRTAP20-2 | KRTAP21-1 | Q3LI58 | 631 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6
Diamond homologs: Q3LI61, Q3LI63, Q3LI72, Q3SYF9, Q3LI70, Q3LI73, Q7Z4W3, Q8IUB9, Q99NG9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 5 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
83 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30635291:G:GA | donor_gain | 0.8400 |
| 21:30635290:T:TA | donor_gain | 0.8000 |
| 21:30635309:G:GT | donor_gain | 0.7800 |
| 21:30635292:G:GG | donor_gain | 0.7500 |
| 21:30635437:A:G | donor_gain | 0.6600 |
| 21:30635326:C:G | donor_gain | 0.6400 |
| 21:30635269:C:CG | donor_gain | 0.6300 |
| 21:30635324:G:GA | donor_gain | 0.6000 |
| 21:30635433:G:GT | donor_gain | 0.5900 |
| 21:30635398:C:G | donor_gain | 0.5800 |
| 21:30635292:GTC:G | donor_gain | 0.5500 |
| 21:30635293:TCT:T | donor_gain | 0.5500 |
| 21:30635305:C:G | donor_gain | 0.5500 |
| 21:30635462:G:GT | donor_gain | 0.5500 |
| 21:30635342:G:GA | donor_gain | 0.5300 |
| 21:30635304:GC:G | donor_gain | 0.5200 |
| 21:30635323:T:TA | donor_gain | 0.5000 |
| 21:30635396:G:GA | donor_gain | 0.5000 |
| 21:30635433:G:T | donor_gain | 0.4900 |
| 21:30635289:G:GT | donor_gain | 0.4700 |
| 21:30635559:A:G | acceptor_gain | 0.4700 |
| 21:30635428:C:G | donor_gain | 0.4600 |
| 21:30635355:GC:G | donor_gain | 0.4500 |
| 21:30635538:G:GG | donor_gain | 0.4500 |
| 21:30635395:T:TA | donor_gain | 0.4400 |
| 21:30635445:C:A | donor_gain | 0.4400 |
| 21:30635294:C:A | donor_gain | 0.4300 |
| 21:30635356:C:G | donor_gain | 0.4300 |
| 21:30635361:G:GT | donor_gain | 0.4300 |
| 21:30635487:G:GA | donor_gain | 0.4300 |
AlphaMissense
394 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30635453:T:C | F64L | 0.866 |
| 21:30635455:C:A | F64L | 0.866 |
| 21:30635455:C:G | F64L | 0.866 |
| 21:30635456:T:G | Y65D | 0.645 |
dbSNP variants (sampled 300 via entrez): RS1000305313 (21:30635540 A>T), RS1001039903 (21:30634172 T>G), RS1002477311 (21:30635215 G>A), RS1004296604 (21:30634468 G>A), RS1004588494 (21:30633390 A>G), RS1004648859 (21:30634649 A>C), RS1005709975 (21:30636010 G>T), RS1006968021 (21:30635618 C>G,T), RS1008396461 (21:30634222 G>A), RS1008910124 (21:30633861 T>G), RS1011896990 (21:30635062 A>T), RS1012014737 (21:30633418 T>C), RS1013160698 (21:30633455 T>C), RS1013879201 (21:30636101 C>T), RS1014308224 (21:30635203 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, decreases methylation, increases methylation | 1 |
| Fulvestrant | decreases methylation, affects cotreatment | 1 |
| Estradiol | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.